EP 4045014 A1 20220824 - CONTROLLED RELEASE FORMULATIONS OF HIGHLY LIPOPHILIC PHYSIOLOGICALLY ACTIVE SUBSTANCES
Title (en)
CONTROLLED RELEASE FORMULATIONS OF HIGHLY LIPOPHILIC PHYSIOLOGICALLY ACTIVE SUBSTANCES
Title (de)
KONTROLLIERT FREISETZENDE FORMULIERUNGEN STARK LIPOPHILER PHYSIOLOGISCH AKTIVER SUBSTANZEN
Title (fr)
FORMULATIONS À LIBÉRATION CONTRÔLÉE DE SUBSTANCES PHYSIOLOGIQUEMENT ACTIVES HAUTEMENT LIPOPHILES
Publication
Application
Priority
- EP 19203580 A 20191016
- EP 2020079248 W 20201016
Abstract (en)
[origin: CA3157654A1] The invention relates to a solid dosage form that comprises a matrix with one or more highly lipophilic physiologically active substances, one or more water-soluble binders and, relative to the weight of all components, not more than 20 wt% of other auxiliary substances.
IPC 8 full level
A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 31/05 (2006.01); A61K 31/352 (2006.01)
CPC (source: EP IL US)
A61K 9/1652 (2013.01 - EP IL); A61K 9/167 (2013.01 - EP IL); A61K 9/1676 (2013.01 - EP IL); A61K 9/2054 (2013.01 - EP IL US); A61K 9/2813 (2013.01 - US); A61K 9/2866 (2013.01 - US); A61K 31/05 (2013.01 - EP IL); A61K 31/352 (2013.01 - EP IL); A61K 31/658 (2023.05 - US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
EP 3808341 A1 20210421; AU 2020365443 A1 20220602; BR 112022006643 A2 20220712; CA 3157654 A1 20210422; CN 114945353 A 20220826; EP 4045014 A1 20220824; IL 292018 A 20220601; JP 2022553653 A 20221226; MX 2022004523 A 20220919; US 2024139215 A1 20240502; WO 2021074403 A1 20210422
DOCDB simple family (application)
EP 19203580 A 20191016; AU 2020365443 A 20201016; BR 112022006643 A 20201016; CA 3157654 A 20201016; CN 202080072328 A 20201016; EP 2020079248 W 20201016; EP 20800800 A 20201016; IL 29201822 A 20220406; JP 2022521684 A 20201016; MX 2022004523 A 20201016; US 202017769424 A 20201016